CIRTRAN CORP Annual Report - How They Did This Year

I’m putting together a simple guide to help you understand how Cirtran Corp performed this year. My goal is to turn complex filings into plain English so you can decide if this company fits your investment goals.

1. What does this company do?

Cirtran Corp acts as a middleman in the supply chain, manufacturing and distributing consumer goods. They rely on licensing deals to run their business. Currently, almost all their money comes from a deal with GloBrands, LLC. This allows Cirtran to make and sell "HUSTLER®" branded items, such as condoms, energy drinks, and tobacco accessories. They also market themselves as a "Concept to Consumer" partner, helping other brands with product design, manufacturing, shipping, and marketing.

2. Financial performance and health

Cirtran’s financial situation is shaky. They consistently lose money and rely heavily on outside funding to stay afloat.

• Survival Mode: Since a 2016 restructuring involving legal settlements and asset sales, the company has operated with very little cash. Revenue is inconsistent and often fails to cover basic bills.
• The Debt Trap: The company carries significant debt, including loans that can be converted into stock. Nearly all their assets—including their intellectual property and inventory—are pledged as collateral. These debts are due by April 2027. If Cirtran cannot pay or renegotiate, they could lose everything to their lenders.
• Capital Needs: The company does not have enough cash to cover its short-term obligations. Management requires additional capital to maintain operations, but they have no guaranteed sources of funding or credit lines.

3. Major wins and challenges

• HUSTLER® Dependency: Almost 100% of the company’s revenue comes from the GloBrands deal. If GloBrands loses its license or Cirtran misses sales goals, the company’s only source of income could vanish.
• The "Going Concern" Warning: Auditors have issued a "going concern" warning. This reflects the reality that the company continues to lose money and struggles to generate enough cash from its operations to sustain itself.
• Operational Hurdles: Cirtran lacks the scale needed to compete effectively. They face challenges in finding reliable, affordable manufacturing and shipping partners, which limits their ability to grow their "Concept to Consumer" business.

4. Key risks for investors

• Dilution: The company raises money by issuing loans that turn into stock. When these convert, the company issues more shares. This reduces your ownership percentage and often puts downward pressure on the share price.
• Penny Stock Status: Cirtran is a "penny stock." This means it is hard to trade, the price can swing wildly, and it is prone to volatility. You may find it difficult to sell your shares without impacting the stock price.
• Speculative Ventures: Management is attempting to move into new areas like home and health products. These ventures are unproven, and the company lacks the marketing budget to compete with established brands.

5. Future outlook

Management aims to find new manufacturing clients to reduce their reliance on the HUSTLER® brand. However, with a market value of only about $94,000 and a history of negative equity, this is a highly speculative "micro-cap" investment. You should view this as a high-risk situation focused on corporate survival rather than growth or dividends.

Final Thought for Investors: Before considering an investment, weigh the company's extreme reliance on a single licensing contract against its significant debt load and the "going concern" warning from auditors. This is a high-risk scenario where the primary focus is on the company's ability to remain in business.